Imperagen

Imperagen is a biotechnology research company focused on enzyme engineering, artificial intelligence, and synthetic biology.

Health and bio

Imperagen has no funding amount on record yet; its latest known round is Seed (May 2026). Recent Funding first saw it on October 2, 2026.

Founders and team

• AC
  Andrew Currin Founder

  source: crunchbase.com
• AA
  Andy Almond Founder

  source: crunchbase.com
• TE
  Timothy Eyes Founder

  source: crunchbase.com

Raise history

1. May 20, 2026
   Seed · amount undisclosed
   Source: crunchbase.com

Related ai companies

• GGood Tape$600K · Oct 2, 2026
• 11club AI$2.2M · Oct 1, 2026
• PPredictive AIOct 1, 2026
• JJAOPS$260M · Oct 1, 2026
• EestaieOct 1, 2026
• OOpensOct 1, 2026
• KKeepsake Family HistoryOct 1, 2026
• MMetisJeanOct 1, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/imperagen.